The PTAB Denies United Therapeutics Request For A Rehearing Of The $UTHR ‘793 Patent Invalidation Decision
https://ptacts.uspto.gov/ptacts/public-informations/petitions/1545682/download-documents?artifactId=170521156
Earnings Scheduled For November 8, 2022
Companies Reporting Before The Bell
• Adtran (NASDAQ:ADTN) is likely to report quarterly earnings at $0.18 per share on revenue of $330.39 million.
‘Interesting motion by Liquidia asking the judge for a stay of enforcement of paragraph 4 of the courts final judgment pending appeal’ – TradeHawk
https://www.docdroid.com/SeBJgoS/liquidia-stay-motion-pdf
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Gainers
Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
Needham Maintains Buy on Liquidia, Raises Price Target to $16
Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $12 to $16.
Ladenburg Thalmann Reiterates Buy Rating On Liquidia, Sets $15 Price Target
https://ladenburg.bluematrix.com/sellside/EmailDocViewer?encrypt=40fcb74c-0d37-4f68-8565-005ab64b6269&mime=pdf&co=Ladenburg&id